{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:21:55Z","timestamp":1777868515201,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472189"],"award-info":[{"award-number":["81472189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672287"],"award-info":[{"award-number":["81672287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702288"],"award-info":[{"award-number":["81702288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672284"],"award-info":[{"award-number":["81672284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702291"],"award-info":[{"award-number":["81702291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["16QNP106"],"award-info":[{"award-number":["16QNP106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.canlet.2019.03.027","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T03:11:25Z","timestamp":1553224285000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer"],"prefix":"10.1016","volume":"452","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dadong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.03.027_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Investigators, osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1158\/1078-0432.CCR-15-2815","article-title":"Targeting the gatekeeper: osimertinib in EGFR T790M mutation-positive non-small cell lung cancer","volume":"23","author":"Skoulidis","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib3","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","article-title":"Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Investigators, osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"Janne","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib8","doi-asserted-by":"crossref","first-page":"11815","DOI":"10.1038\/ncomms11815","article-title":"Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients","volume":"7","author":"Chabon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.03.027_bib9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/JTO.0000000000000688","article-title":"Mechanisms of acquired resistance to AZD9291: a mutation-selective, irreversible EGFR inhibitor","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2019.03.027_bib10","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/annonc\/mdv319","article-title":"EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients","volume":"26","author":"Planchard","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.03.027_bib11","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1158\/1078-0432.CCR-15-1915","article-title":"Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors","volume":"22","author":"Ortiz-Cuaran","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cas.12905","article-title":"Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer","volume":"107","author":"Mizuuchi","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2019.03.027_bib13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-14-3167","article-title":"Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models","volume":"75","author":"Eberlein","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib14","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/0008-5472.CAN-16-2359","article-title":"Amplification of EGFR wild-type Alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors","volume":"77","author":"Nukaga","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","article-title":"Autophagy pathway: cellular and molecular mechanisms","volume":"14","author":"Yu","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.03.027_bib16","doi-asserted-by":"crossref","first-page":"OF10","DOI":"10.1158\/2159-8290.CD-RW2014-059","article-title":"BRAF inhibitor resistance can be overcome by blocking autophagy","volume":"4","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.03.027_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood-2016-07-692707","article-title":"Autophagy, a key mechanism of oncogenesis and resistance in leukemia","volume":"129","author":"Auberger","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.03.027_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1078-0432.CCR-15-0987","article-title":"ROS-induced CXCR4 signaling regulates mantle cell lymphoma (MCL) cell survival and drug resistance in the bone marrow microenvironment via autophagy","volume":"22","author":"Chen","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2013.08.015","article-title":"EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance","volume":"154","author":"Wei","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.03.027_bib20","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3892\/ijo.2016.3468","article-title":"Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress","volume":"48","author":"Wang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.03.027_bib21","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1038\/s41598-017-04258-8","article-title":"Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.03.027_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/15548627.2016.1164357","article-title":"Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia","volume":"12","author":"Chen","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.03.027_bib23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcb.27434","article-title":"AZD9291 promotes autophagy and inhibits PI3K\/Akt pathway in NSCLC cancer cells","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2019.03.027_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2017.02.017","article-title":"Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells","volume":"321","author":"Tang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2019.03.027_bib25","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.1009472107","article-title":"TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer","volume":"107","author":"Yao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.03.027_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2019.03.027_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/embor.2008.238","article-title":"PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation","volume":"10","author":"N'Diaye","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2019.03.027_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncb2886","article-title":"Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1","volume":"16","author":"Gump","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2019.03.027_bib29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib30","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1158\/0008-5472.CAN-15-2946","article-title":"Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR\/Stat3 and tgfbeta\/smad signaling","volume":"76","author":"Yeo","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/M15-0308","article-title":"Effects on clinical outcomes of adding dipeptidyl peptidase-4 inhibitors versus sulfonylureas to metformin therapy in patients with type 2 diabetes mellitus","volume":"163","author":"Ou","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canlet.2019.03.027_bib32","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","article-title":"CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist","volume":"74","author":"Sarvi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/pin.12019","article-title":"Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and beta-catenin, in primary lung adenocarcinoma--their prognostic significance","volume":"62","author":"Okudela","year":"2012","journal-title":"Pathol. Int."},{"key":"10.1016\/j.canlet.2019.03.027_bib34","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/jca.19732","article-title":"Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma","volume":"8","author":"Nishino","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2019.03.027_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/JTO.0000000000000021","article-title":"Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization","volume":"9","author":"Sterlacci","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2019.03.027_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccr.2014.01.008","article-title":"The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma","volume":"25","author":"Justilien","year":"2014","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2019.03.027_bib37","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1038\/cddis.2012.93","article-title":"Non-small cell lung cancer stem\/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity","volume":"3","author":"Akunuru","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2019.03.027_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2014.03.021","article-title":"SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines","volume":"85","author":"Dogan","year":"2014","journal-title":"Lung Canc."},{"key":"10.1016\/j.canlet.2019.03.027_bib39","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/onc.2013.373","article-title":"Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling","volume":"33","author":"Kim","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.03.027_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9040027","article-title":"EGFR family members' regulation of autophagy is at a crossroads of cell survival and death in cancer","volume":"9","author":"Henson","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2019.03.027_bib41","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1074\/jbc.M710169200","article-title":"Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.03.027_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.leukres.2010.05.029","article-title":"p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes","volume":"35","author":"Amrein","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib43","first-page":"0","article-title":"MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells","author":"Lee","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.03.027_bib44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/cas.12749","article-title":"Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib","volume":"106","author":"Hashida","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2019.03.027_bib45","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-12-4136","article-title":"Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells","volume":"73","author":"Shien","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib46","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.18632\/oncotarget.3389","article-title":"IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.03.027_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature21388","article-title":"Autophagy maintains the metabolism and function of young and old stem cells","volume":"543","author":"Ho","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.03.027_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13046-017-0644-8","article-title":"Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2","volume":"36","author":"Peng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res. : CR (Clim. Res.)"},{"key":"10.1016\/j.canlet.2019.03.027_bib49","doi-asserted-by":"crossref","first-page":"e2943","DOI":"10.1038\/cddis.2017.327","article-title":"Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells","volume":"8","author":"Pagotto","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2019.03.027_bib50","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1080\/15548627.2017.1336277","article-title":"Autophagy-induced KDR\/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells","volume":"13","author":"Wu","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.03.027_bib51","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1158\/1078-0432.CCR-16-1903","article-title":"AMPK-ULK1-Mediated autophagy confers resistance to BET inhibitor JQ1 in acute myeloid leukemia stem cells","volume":"23","author":"Jang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.03.027_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fcell.2018.00137","article-title":"Beclin 1 phosphorylation - at the center of autophagy regulation","volume":"6","author":"Menon","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2019.03.027_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2012.12.016","article-title":"Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy","volume":"152","author":"Kim","year":"2013","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:03:04Z","timestamp":1777550584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519301831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":53,"alternative-id":["S0304383519301831"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.03.027","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/330092","asserted-by":"object"}]},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}